The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

JL Hsu, MC Hung - Cancer and Metastasis Reviews, 2016 - Springer
Breast cancer affects approximately 1 in 8 women, and it is estimated that over 246,660
women in the USA will be diagnosed with breast cancer in 2016. Breast cancer mortality has …

Targeting the EGFR signaling pathway in cancer therapy

P Seshacharyulu, MP Ponnusamy… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Cancer is a devastating disease; however, several therapeutic advances have
recently been made, wherein EGFR and its family members have emerged as useful …

Multifunctional nanoplatforms for subcellular delivery of drugs in cancer therapy

X Guo, X Wei, Z Chen, X Zhang, G Yang… - Progress in Materials …, 2020 - Elsevier
To achieve highly effective treatment to diseases, successful delivery of drugs with a carrier
into the specific organelles (nucleus, mitochondria, lysosomes, etc.) is of great importance …

Understanding resistance to EGFR inhibitors—impact on future treatment strategies

DL Wheeler, EF Dunn, PM Harari - Nature reviews Clinical oncology, 2010 - nature.com
EGFR is a tyrosine kinase that participates in the regulation of cellular homeostasis.
Following ligand binding, EGFR stimulates downstream cell signaling cascades that …

Expression and function of the epidermal growth factor receptor in physiology and disease

J Chen, F Zeng, SJ Forrester, S Eguchi… - Physiological …, 2016 - journals.physiology.org
The epidermal growth factor receptor (EGFR) is the prototypical member of a family of
membrane-associated intrinsic tyrosine kinase receptors, the ErbB family. EGFR is activated …

Protein localization in disease and therapy

MC Hung, W Link - Journal of cell science, 2011 - journals.biologists.com
The eukaryotic cell is organized into membrane-covered compartments that are
characterized by specific sets of proteins and biochemically distinct cellular processes. The …

EGFR signaling enhances aerobic glycolysis in triple-negative breast cancer cells to promote tumor growth and immune escape

SO Lim, CW Li, W Xia, HH Lee, SS Chang, J Shen… - Cancer research, 2016 - AACR
Oncogenic signaling reprograms cancer cell metabolism to augment the production of
glycolytic metabolites in favor of tumor growth. The ability of cancer cells to evade …

Nuclear EGFR as a molecular target in cancer

TM Brand, M Iida, N Luthar, MM Starr… - Radiotherapy and …, 2013 - Elsevier
The epidermal growth factor receptor (EGFR) has been one of the most targeted receptors in
the field of oncology. While anti-EGFR inhibitors have demonstrated clinical success in …

EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment

G Liccardi, JA Hartley, D Hochhauser - Cancer research, 2011 - AACR
Epidermal growth factor receptor (EGFR) overexpression is associated with resistance to
chemotherapy and radiotherapy. It modulates DNA repair after radiation-induced damage …

Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab

TM Brand, M Iida, DL Wheeler - Cancer biology & therapy, 2011 - Taylor & Francis
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase belonging to the
HER family of receptor tyrosine kinases. Receptor activation upon ligand binding leads to …